About LIBTAYO
Libtayo was established in 2012 in Tarrytown, United States, within the pharmaceutical sector. Operations center on cancer treatment medicines, with resources and information made available through the domain libtayo.com. The platform serves as the official source for details on immunotherapy options, targeting various cancer types. Geographic focus remains in the United States, supporting healthcare professionals and patients with factual data on treatment protocols and availability.
- Headquarter Tarrytown, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Libtayo Corporation
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
-
Acquired by
Regeneron Pharmaceuticals
(Jun 02, 2022)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of LIBTAYO
Detailed funding history for LIBTAYO
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in LIBTAYO
LIBTAYO has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Regeneron Pharmaceuticals.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Antibodies are developed for treating cancer, eye, and inflammatory diseases.
|
Locked | Locked | Locked |
Investor details for LIBTAYO
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by LIBTAYO
Investment portfolio details for LIBTAYO
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - LIBTAYO
Detailed financials for LIBTAYO
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Libtayo Comparisons
Peer comparison for LIBTAYO
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of LIBTAYO
Detailed competitors of LIBTAYO
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Libtayo
Complete news archive for LIBTAYO
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about LIBTAYO
LIBTAYO was founded in 2012.
LIBTAYO is headquartered in Tarrytown, United States. It is registered at Tarrytown, New York, United States.
Libtayo was established in 2012 in Tarrytown, United States, within the pharmaceutical sector. Operations center on cancer treatment medicines, with resources and information made available through the domain libtayo.com. The platform serves as the official source for details on immunotherapy options, targeting various cancer types. Geographic focus remains in the United States, supporting healthcare professionals and patients with factual data on treatment protocols and availability.
LIBTAYO has 1 investor. Key investors include Regeneron Pharmaceuticals.